Mucocutaneous Lymph Node Syndrome

"Mucocutaneous Lymph Node Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.

Descriptor ID	D009080
MeSH Number(s)	C14.907.940.560 C15.604.560 C17.800.862.560
Concept/Terms	Mucocutaneous Lymph Node Syndrome Mucocutaneous Lymph Node Syndrome Kawasaki Syndrome Lymph Node Syndrome, Mucocutaneous Kawasaki Disease

Below are MeSH descriptors whose meaning is more general than "Mucocutaneous Lymph Node Syndrome".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Vasculitis [C14.907.940]
Mucocutaneous Lymph Node Syndrome [C14.907.940.560]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Mucocutaneous Lymph Node Syndrome [C15.604.560]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Skin Diseases, Vascular [C17.800.862]
Mucocutaneous Lymph Node Syndrome [C17.800.862.560]

Below are MeSH descriptors whose meaning is related to "Mucocutaneous Lymph Node Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Mucocutaneous Lymph Node Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mucocutaneous Lymph Node Syndrome" by people in this website by year, and whether "Mucocutaneous Lymph Node Syndrome" was a major or minor topic of these publications.

Bar chart showing 10 publications over 7 distinct years, with a maximum of 2 publications in 2005 and 2021 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	0	1
1998	1	0	1
2005	2	0	2
2018	0	1	1
2021	0	2	2
2022	2	0	2

Below are the most recent publications written about "Mucocutaneous Lymph Node Syndrome" by people in Profiles.

Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, Imundo LF, Lapidus SK, Kim S, Son MB, Sule S, Tremoulet AH, Van Mater H, Yildirim-Toruner C, Langford CA, Maz M, Abril A, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Merkel PA, Rhee RL, Seo P, Stone JH, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot M, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Rheumatol. 2022 04; 74(4):586-596.

View in: PubMed
Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, Imundo LF, Lapidus SK, Kim S, Son MB, Sule S, Tremoulet AH, Van Mater H, Yildirim-Toruner C, Langford CA, Maz M, Abril A, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Merkel PA, Rhee RL, Seo P, Stone JH, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot M, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Care Res (Hoboken). 2022 04; 74(4):538-548.

View in: PubMed
Gidding SS. 50 Years Ago in TheJournalofPediatrics: Inflammation and Vasculitis: Changing Paradigms. J Pediatr. 2021 06; 233:205.

View in: PubMed
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Ferris A, Kernan KF, Schulert GS, Seo P, Son MBF, Tremoulet AH, Yeung RSM, Mudano AS, Turner AS, Karp DR, Mehta JJ. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. Arthritis Rheumatol. 2021 Apr; 73(4):e13-e29.

View in: PubMed
Wolf R, Parish JL, Parish LC. The rash that presents as target lesions. Clin Dermatol. 2019 Mar - Apr; 37(2):148-158.

View in: PubMed
McCulloch MA, Gutgesell HP, Saulsbury FT, Hellems M, Hammill WW, Lim DS. Limitations of echocardiographic periarterial brightness in the diagnosis of Kawasaki disease. J Am Soc Echocardiogr. 2005 Jul; 18(7):768-70.

View in: PubMed
Simonini G, Ros? CD, Vierucci A, Falcini F, Athreya BH. Diagnosing Kawasaki syndrome: the need for a new clinical tool. Rheumatology (Oxford). 2005 Aug; 44(8):959-61.

View in: PubMed
Miura N, Terai M, Meng YG, Sato T, Niimi H. Serum thrombopoietin levels in Kawasaki disease. Br J Haematol. 1998 Feb; 100(2):387-8.

View in: PubMed
Cabana VG, Gidding SS, Getz GS, Chapman J, Shulman ST. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res. 1997 Nov; 42(5):651-5.

View in: PubMed
Athreya BH. Vasculitis in children. Curr Opin Rheumatol. 1996 Sep; 8(5):477-84.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement